DISCLAIMER This information represents neither an offer to buy or sell any security nor, because it does not take into account the differing needs of individual clients, investment advice. Those seeking investment advice specific to their financial profiles and goals should contact their Oscar Gruss & Son Incorporated sales representative. Oscar Gruss & Son Incorporated believes this information to be reliable, but no representation is made as to accuracy or completeness. This information does not analyze every material fact concerning a company, industry, or security. Oscar Gruss & Son Incorporated assumes that this information will be read in conjunction with other publicly available data. Matters discussed here are subject to change without notice. There can be no assurance that reliance on the information contained here will produce profitable results. A security denominated in a foreign currency is subject to fluctuations in currency exchange rates, which may have an adverse effect on the value of the security upon the conversion into local currency of dividends, interest, or sales proceeds. The value of securities and depositary receipts of foreign issuers that are denominated in United States dollars are also influenced by fluctuations in currency exchange rates. © 2020 Oscar Gruss & Son Incorporated. All rights reserved.Today:
ALAC S/H Redemption Deadline
BMRG/Eos Energy BMRG S/H Record Date (expected, per NYSE)
DPHC/Lordstown Motors DPHC Special Meeting in Lieu of 202 0 Annual Meeting 10:00am ET
KBLM/CannBioRx KBLM S/H Redemption Deadline 5:00pm ET
LGC/Onyx Enterprises Joint Presentation at Webinar Hosted by SPACInsider and ICR 2:00pm ET
RICE/U First Day of Trading
SRAC/Momentus Inc. HSR Filing Deadline
ACAM/CarLotz, Inc, Announce Business Combination
Investor Conference Call Information
CarLotz and Acamar Partners will host a joint investor conference call to discuss the proposed transaction on Thursday, October 22 at 9:00 am ET.
Interested parties may listen to the conference call via telephone by dialing 1-877-451-6152, or for international callers, 1-201-389-0879. A telephone replay will be available until 11:59 pm ET on October 29, 2020 and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671 and entering replay Pin number: 13712290.
Signs merger pact with 4D Pharma PLC (AIM: DDDD LN)
The deal is worth up to $37.6 million to 4D pharma. As a result of the merger, 4D pharma plans to launch a new NASDAQ-listed American Depositary Share (ADS) programme under the ticker symbol ‘LBPS’ and will immediately be admitted to trading on NASDAQ upon completion. 4D pharma will become dual-listed and ordinary shares will continue to be traded on AIM under the ticker symbol ‘DDDD’.
DDDD LN with terms/background to transaction
Prices IPO
The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Thursday, October 22, 2020, under the ticker symbol "TEKKU".
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units commence separate trading, the Class A ordinary shares and redeemable warrants are expected to be respectively listed on Nasdaq under the symbols “TEKK” and “TEKKW”. The offering is expected to close on October 26, 2020, subject to customary closing conditions.
Fisker CEO interview with Jim Cramer 10/21/20 transcript
Prices IPO
The units will be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “CTAC.U” beginning on October 22, 2020. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “CTAC” and “CTAC WS,” respectively. The initial public offering is expected to close on October 26, 2020, subject to customary closing conditions.
Prices IPO
The units will be listed on the NASDAQ Stock Market, LLC (“NASDAQ”) and will trade under the ticker symbol “YSACU” beginning on October 22, 2020. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-half of one warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50 per share. The offering is expected to close on October 26, 2020, subject to satisfaction of customary closing conditions. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on NASDAQ under the symbols “YSAC” and “YSACW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
Prices IPO
announced the pricing of its initial public offering of 12,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares will be listed on the Nasdaq Capital Market and trade under the ticker symbol “BLSA” beginning on October 22, 2020.
On October 19, 2020, Mr. John W. Allen resigned from his positions as an independent director and the chairman of the compensation committee of Alberton Acquisition Corporation (the “Company”) and Mr. Harry Edelson resigned from his positions as an independent director and the chairman of audit committee of the Company. Their resignation did not result from a disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On October 20, 2020, the Board appointed Mr. William Walter Young as an independent director and the chairman of the compensation committee and Mr. Qing S. Huang as an independent director and the chairman of the audit committee of the Board of the Company to fill the vacancies created by Mr. Allen and Mr. Edelson, effective immediately.
As a result, the Board currently have two executive directors and three independent directors.
The Company is currently completing the due diligence and negotiation of a definitive agreement to merge with a domestic integrated solar and renewable energy company, which has operations in both the United States and China, and it expects to enter into a definitive agreement by October 30, 2020.
Files updated investor presentation
Prices IPO
The units will be listed on the New York Stock Exchange (the "NYSE") and trade under the ticker symbol "RICE U" beginning on October 22, 2020. Each unit consists of one share of the Company's Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of the Company's Class A common stock at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on the NYSE under the symbols "RICE" and "RICE WS," respectively.
S-1/A#3 Filed (redline attached)
Add “Certain qualified institutional buyers or institutional accredited investors not affiliated with our sponsor or any member of our management have indicated to us that they each intend to purchase units in this offering at a level of up to 9.9% of the units subject to this offering. In consideration of this, our sponsor has agreed that these investors will purchase membership interests in our sponsor, for nominal consideration, entitling them to an interest in an aggregate of up to 270,000 founder shares held by our sponsor. In addition, another institutional investor and existing member of our sponsor has provided an indication of interest in purchasing units in this offering and will be participating in the purchase of the private placement warrants through our sponsor. See the section titled “Certain Relationships and Related Party Transactions” for further information.” (p.3), Anchor founder shares disclosures (p.15)
Crescent Acquisition Corp (the “Company”) currently intends to hold its first Annual Meeting of Stockholders (the “Annual Meeting”) on December 17, 2020, at a time and location to be determined and specified in the Company’s definitive proxy statement related to the Annual Meeting.
ION Acquisition Corp 1 Ltd. Announces Separate Trading of its Ordinary Shares and Warrants, Commencing October 27, 2020
On October 21, 2020, Tenzing Acquisition Corp. (Nasdaq: TZAC, TZACW, TZACU) , a special purpose acquisition company organized under the laws of the British Virgin Islands (together with its successors, the “Company” or “Tenzing”), entered into backstop agreements (each, a “Backstop Agreement”) with Reviva Pharmaceuticals, Inc., a Delaware corporation (“Reviva”), and certain investors (the “Backstop Investors”) in connection with the Company’s previously announced proposed business combination (the “Reviva Business Combination”) with Reviva.
GCM Grosvenor Raises its 2020 Adjusted EBITDA and Adjusted Net Income Guidance; Announces Special Meeting of CFAC Stockholders and Board of Directors
From Yesterday:
SOC Telemed and HCCO Announce Special Meeting Date and Identify New Director Nominees in Anticipation of Close of Business Combination
AppHarvest Opens One of the World’s Largest High-Tech Greenhouses in Appalachia to Redefine American Agriculture
Investor Presentation Filed
Reports Closing of IPO, Sale of Private Placement Warrants
On October 19, 2020, Spartacus Acquisition Corporation, a Delaware corporation (the “Company”), consummated its initial public offering (the “IPO”) of 20,000,000 units (the “Units”).
Simultaneously with the closing of the IPO, pursuant to the Warrant Subscription Agreements, the Company completed the private sale of an aggregate of 8,750,000 Warrants (the “Private Placement Warrants”). 8,104,244 of the Private Placement Warrants were sold to the Sponsor and 645,756 of the Private Placement Warrants were sold to B. Riley Principal Investments, LLC at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $8,750,000.
Reports Over-Allotment in Connection with IPO
In connection with the closing and sale of the Over-Allotment Units and 1,000,000 additional Private Placement Warrants (together, the “Over-Allotment Closing”), a total of $50,000,000 comprised of $49,000,000 of the proceeds from the closing and sale of the Over-Allotment Units (which amount includes $1,750,000 of the Underwriters’ deferred discount) and $1,000,000 of the proceeds of the sale of the additional 1,000,000 Private Placement Warrants, was placed in a U.S.-based trust account, with Continental Stock Transfer & Trust Company acting as trustee. As a result of the Underwriters’ partial exercise of the over-allotment option, the Sponsor forfeited 250,000 shares of the Company’s Class B common stock, $0.0001 par value per share.
AGBA Announces Change in Certifying Accountant
On October 15, 2020, AGBA Acquisition Limited (the “Company”) dismissed Marcum LLP (“Marcum”) as its independent registered public accounting firm. Effective October 20, 2020, Friedman LLP (“Friedman”) has been engaged as the Company’s new independent registered public accounting firm. The audit committee of the Company’s board of directors (the “Audit Committee”), on October 15, 2020, approved the dismissal of Marcum and the engagement of Friedman as the independent registered public accounting firm.
424B4 Filed
424B4 Filed
S-1/A#1 Filed
Exhibits only
424B4 Filed
S-1/A#2 Filed (redline attached)
Reduces size of IPO from $300M to $250M (p.14)
S-1/A#1 Filed
change ticker from ARBGU, ARBGW to ARBG/U and ARBG/W